| Literature DB >> 33913863 |
Smith Snehal Sute1, Suksham Jain2, Deepak Chawla2, Subina Narang1.
Abstract
Purpose: Inopathy of prematurity (WINROP) Weight, insulin-derived growth factor 1, neonatal ROP algorithm is an online tool that has been validated as a predictor of retinopathy of prematurity (ROP) in various countries. The current study was designed to evaluate the predictive ability of WINROP algorithm (http://winrop.com) using postnatal weight gain in detecting Type 1 ROP in Indian babies.Entities:
Keywords: Risk factors for ROP; Type 1 ROP; WINROP
Mesh:
Substances:
Year: 2021 PMID: 33913863 PMCID: PMC8186583 DOI: 10.4103/ijo.IJO_1521_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Figue 1Flow chart of the study
Neonatal characteristics of WINROP eligible infants in alarm vs no alarm group
| Neonatal characters | Alarm ( | No alarm ( | |
|---|---|---|---|
| Gender (Male) | 18 (47.%) | 26 (40.6) | 0.506 |
| Gestation at birth (weeks)* | 29.3±1.4 | 30.4±1.2 | 0.001‡ |
| Birth weight (grams)* | 1104±165 | 1545±233 | 0.001‡ |
| Small for gestation (SGA) | 7 (18.4%) | 2 (3.1%) | 0.008‡ |
| Apgar at 5 min | 7.66±2.044 | 8.73±0.859 | 0.001‡ |
| Respiratory distress syndrome (RDS) | 25 (65.8%) | 28 (43.8%) | 0.031‡ |
| Transient tachypnoea of new-born (TTNB) | 2 (5.3%) | 3 (4. 7%) | 0.896 |
| Patent ductus arteriosus (PDA) | 23 (60.5%) | 12 (18.8%) | 0.001‡ |
| Proven early onset sepsis | 5 (13.2%) | 5 (7.8%) | 0.380 |
| Meningitis | 3 (7.9%) | 1 (1.6%) | 0.111 |
| Use of ionotropic drug | 7 (18.4%) | 3 (4.7%) | 0.024‡ |
| Intraventricular hemorrhage (IVH) | 7 (18.4%) | 3 (4.7%) | 0.024‡ |
| Jaundice requiring treatment | 19 (50%) | 32 (50%) | 1 |
| Exchange transfusion | 1 (2.6%) | 1 (1.6%) | 0.707 |
| Days of mechanical ventilation (invasive)* | 3.42±4.785 | 1.20±2.476 | 0.003‡ |
| Days of oxygen support other than ventilation* | 1.79±2.549 | 1.50±3.152 | 0.632 |
| Weight gain in the first week (grams)§ | -60.0 (125, -19.0) | -85.0 (-149.5, -47.5) | 0.21 |
| Weight gain in the second week (grams)§ | -60 (28.0 90.0) | 45.0 (15.0, 77.0) | 0.19 |
| Weight gain in the third week (grams)§ | 72 (50.0, 110.0) | 80.0 (6.0, 108.0) | 0.73 |
| Weight gain in the fourth week (grams)§ | 45 (10.5, 78.5 | 102 (50.0, 130.0) | 0.062 |
*Values are expressed in mean±SD, †n (%), ‡P<0.05 significant, §IQR: Interquartile range
Neonatal comorbidities in infants who developed ROP without signaling WINROP alarm
| RDS* | †PDA | IVH‡ | JT§ | BPD|| | SS¶ |
|---|---|---|---|---|---|
| Yes | Yes | Yes | No | No | Yes |
| Yes | No | No | No | No | No |
| No | No | No | Yes | No | No |
| Yes | Yes | No | Yes | No | No |
| Yes | Yes | No | Yes | No | No |
| Yes | No | No | No | Yes | No |
| 83.33% | 50% | 16.67% | 50% | 16.67% | 16.67% |
RDS*: Respiratory distress syndrome, †PDA: Patent ductusarteriosus; ‡IVH: Intraventricular hemorrhage; JT§: Jaundice requiring treatment; BPD||: Bronchopulmonary dysplasia; SS¶: Septic shock
WINROP alarm with location and stage of ROP
| Total | WINROP alarm | No alarm | Fisher’s exact | |
|---|---|---|---|---|
| No ROP | 65 | 8 | 57 | 1.000 |
| Z-I | 5 | 5 | 0 | |
| Z-II | 32 | 25 | 7 | |
| Z-III | 0 | |||
| No ROP | 65 | 8 | 57 | 1.000 |
| S-1 | 1 | 1 | 0 | |
| S-2 | 29 | 22 | 7 | |
| S-3 | 2 | 2 | 0 | |
| APROP | 5 | 5 | 0 | 0.006 |
There was no correlation of the alarm with the zone or stage of ROP. Z*: Zone, †S: Stage; ‡APROP: Aggressive posterior retinopathy of prematurity
Diagnostic performance of WINROP alarm
| Alarm Status | Sensitivity Percentages (95% CI‡) | Specificity | Predictive value | |||
|---|---|---|---|---|---|---|
| Yes | No | PPV* | NPV† | |||
| Type 1 ROP | 24 | 6 | 80 | 80.6 | 63.2 | 90.6 |
| Type 2 ROP | 6 | 1 | 85.7 | 66.3 | 15.8 | 98.4 |
| No ROP | 8 | 57 | 81.1 | 87.7 | 78.9 | 89.1 |
*PPV: Positive predictive value; †NPV: Negative predictive value; ‡CI: Confidence interval